HC poser on resale of expired meds

New Delhi: Delhi high court on Friday sought the Centre’s stand on a PIL that claimed rampant sale of expired drugs by chemists who erase the original manufacturing and expiry dates and re-stamp them.

Terming the issue as “serious”, a bench of Chief Justice Rajendra Menon and Justice V K Rao said the authorities must look into the matter, adding that it appeared such activities were “happening in Kolkata and Ahmedabad”, where expired medicines were re-stamped as unexpired and routed to other places via Delhi.

Issuing notice, the court said central authorities have to look into it and sought replies from ministry of health and family welfare and the Drug Controller General of India. It also sought their replies to advocate Amit Sahni’s plea seeking directions to the government to curb sale of such medicines.

Sahni, in his PIL, claimed that the original manufacturing and expiry dates as well as MRP were erased from expired medicines and the drugs were re-stamped as unexpired to sell them.

The plea said “expired medicines sold as unexpired not only affect the health of the person(s), but the same leads to unnecessary financial burden, which does not serve the purpose in any manner”.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’